Cover Image

The EURO-FORTA (Fit fOR The Aged) list version 2: consensus validation of a clinical tool for improved pharmacotherapy in older adults

The aging of our societies leads to a higher prevalence of multimorbidity and therefore polypharmacy, which often results in inappropriate drug treatment. To address this issue, numerous listing approaches, such as the Fit fOR The Aged (FORTA) list have been developed. FORTA’s positive impact on the...

Full description

Saved in:
Bibliographic Details
Main Authors: Pazan, Farhad (Author) , Weiß, Christel (Author) , Wehling, Martin (Author)
Format: Article (Journal)
Language:English
Published: May 2023
In: Drugs & aging
Year: 2023, Volume: 40, Issue: 5, Pages: 417-426
ISSN:1179-1969
DOI:10.1007/s40266-023-01024-6
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s40266-023-01024-6
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s40266-023-01024-6
Get full text
Author Notes:Farhad Pazan, Christel Weiss, Martin Wehling on behalf of FORTA Expert Panel Members
Description
Summary:The aging of our societies leads to a higher prevalence of multimorbidity and therefore polypharmacy, which often results in inappropriate drug treatment. To address this issue, numerous listing approaches, such as the Fit fOR The Aged (FORTA) list have been developed. FORTA’s positive impact on the quality of medications and relevant clinical outcomes has been shown. Based on new emerging evidence and experiences with the existing FORTA lists, we aimed to update the FORTA lists in several European countries/regions.
Item Description:Online veröffentlicht: 2. Mai 2023
Gesehen am 16.09.2024
Physical Description:Online Resource
ISSN:1179-1969
DOI:10.1007/s40266-023-01024-6

Similar Items